Free Trial

Integer (NYSE:ITGR) Shares Down 7.2% After Earnings Miss

Integer logo with Medical background

Integer Holdings Corporation (NYSE:ITGR - Get Free Report)'s share price was down 7.2% during mid-day trading on Thursday following a dissappointing earnings announcement. The stock traded as low as $107.42 and last traded at $107.38. Approximately 326,647 shares changed hands during mid-day trading, a decline of 33% from the average daily volume of 489,903 shares. The stock had previously closed at $115.77.

The medical equipment provider reported $1.55 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a return on equity of 11.95% and a net margin of 4.38%. During the same quarter in the prior year, the company earned $1.30 earnings per share. The firm's revenue was up 11.4% compared to the same quarter last year.

Analyst Ratings Changes

Several brokerages have issued reports on ITGR. Raymond James Financial raised their target price on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, April 25th. Wall Street Zen raised Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. KeyCorp lowered their price target on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and raised their target price for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Finally, Truist Financial set a $150.00 price target on shares of Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. Two analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $146.25.

Read Our Latest Research Report on ITGR

Insiders Place Their Bets

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the sale, the chief executive officer directly owned 47,000 shares of the company's stock, valued at $5,788,990. This represents a 87.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the completion of the transaction, the director directly owned 22,170 shares in the company, valued at $2,672,815.20. This trade represents a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 362,434 shares of company stock valued at $44,577,115 in the last three months. 2.16% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. AdvisorNet Financial Inc purchased a new position in Integer during the 1st quarter worth approximately $28,000. Opal Wealth Advisors LLC bought a new stake in shares of Integer during the first quarter worth $28,000. Bessemer Group Inc. lifted its stake in Integer by 73.1% in the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after acquiring an additional 125 shares during the last quarter. SVB Wealth LLC acquired a new stake in shares of Integer during the 1st quarter worth about $35,000. Finally, Sterling Capital Management LLC grew its holdings in shares of Integer by 472.9% during the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock valued at $45,000 after purchasing an additional 279 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Stock Performance

The stock has a market cap of $3.71 billion, a price-to-earnings ratio of 50.63, a P/E/G ratio of 0.98 and a beta of 0.98. The company's fifty day simple moving average is $119.27 and its two-hundred day simple moving average is $124.06. The company has a debt-to-equity ratio of 0.78, a current ratio of 3.40 and a quick ratio of 2.14.

Integer Company Profile

(Get Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Integer Right Now?

Before you consider Integer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.

While Integer currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines